Xencor to webcast Phase 1 results of XmAb819 in kidney cancer
Xencor, Inc. (NASDAQ: XNCR) announced it will host a webcast on October 26 at 7:00 a.m. EDT to discuss Phase ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)

